BPG is committed to discovery and dissemination of knowledge
Articles in Press
3/12/2025 6:37:54 AM | Browse: 131 | Download: 0
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Letter to the Editor |
| Article Title |
L-arginine overdose is a potential risk factor for myocardial injury in patients with type 2 diabetes
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yan Chen, Meng-Ting Dai and Guo-Hua Gong |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| The Medical Health Science and Technology Project of Zhejiang Provincial Health Commission |
2024KY138 |
| The Basic Research Project of Wenzhou Municipal Science and Technology Bureau |
Y20240008 |
| The Key Discipline of Zhejiang Province in Medical Technology (First Class, Category A) |
|
| The Key Laboratory of School of Laboratory Medicine and Life Sciences, Wenzhou Medical University of China |
JS2023003 |
|
| Corresponding Author |
Guo-Hua Gong, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, No. 82 West College Road, Wenzhou 325035, Zhejiang Province, China. guohgong@wmu.edu.cn |
| Key Words |
L-arginine; Glucose; Oxidative stress; Antioxidant; Inflamation; Caridac |
| Core Tip |
The effect of L-arginine (L-Arg) daily administration is dependent on its concentration in type II diabetes. Low L-Arg is safe and good for diabetes. However, over 0.5 g/kg L-Arg is a risk factor for the heart. It may aggravate myocardial damage by increasing blood glucose levels, oxidative stress, inflammatory mediator levels, and cardiac remodeling. |
| Citation |
Chen Y, Dai MT, Gong GH. L-arginine overdose is a potential risk factor for myocardial injury in patients with type 2 diabetes. World J Diabetes 2025; 16(5): 104409 |
 |
Received |
|
2025-01-06 03:44 |
|
Peer-Review Started |
|
2025-01-07 01:03 |
|
First Decision by Editorial Office Director |
|
2025-02-13 02:47 |
|
Return for Revision |
|
2025-02-13 02:47 |
|
Revised |
|
2025-02-24 10:55 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-03-12 02:35 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-03-12 06:37 |
|
Articles in Press |
|
2025-03-12 06:37 |
|
Edit the Manuscript by Language Editor |
|
2025-03-13 12:02 |
|
Typeset the Manuscript |
|
2025-04-14 02:35 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
